Interferon alpha for chronic hepatitis B

To assess the beneficial and harmful effects of standard interferon alpha alone as compared with no treatment or placebo for chronic hepatitis B in patients with HBeAg-positive or HBeAg negative status.

This is a protocol.

You may also be interested in:

Interferon for people with lamivudine-resistant chronic hepatitis B virus infection
Interferon beta for chronic hepatitis B
Interferon gamma for chronic hepatitis B
Pegylated interferon for chronic hepatitis B
Glucocorticosteroid pretreatment may increase virologic response to interferon in hepatitis B 'e' antigen positive chronic hepatitis B

Health topics:

Gastroenterology & hepatology > Liver disorders > Hepatitis B

Infectious disease > Liver infections > Hepatitis B

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.